{
  "id": "myocardial_infarction_criteria",
  "type": "diagnostic_criteria",
  "name": "Myocardial Infarction - Universal Definition and Classification",
  "content": "MYOCARDIAL INFARCTION (MI) - FOURTH UNIVERSAL DEFINITION:\n\nDIAGNOSTIC CRITERIA (Requires ≥1):\n1. Detection of rise/fall of cardiac troponin with ≥1 value >99th percentile AND ≥1 of:\n   - Symptoms of myocardial ischemia\n   - New ischemic ECG changes (ST-T changes, LBBB)\n   - Development of pathological Q waves\n   - New loss of viable myocardium or wall motion abnormality (imaging)\n   - Intracoronary thrombus on angiography\n\nCLASSIFICATION:\n- Type 1: Spontaneous MI (plaque rupture, erosion, dissection)\n- Type 2: MI secondary to ischemic imbalance (supply-demand mismatch)\n- Type 3: Cardiac death with suspected MI (sudden death before biomarkers obtained)\n- Type 4a: MI related to PCI\n- Type 4b: MI related to stent thrombosis\n- Type 5: MI related to CABG\n\nSTEMI vs NSTEMI:\n- STEMI: ST elevation ≥1mm in ≥2 contiguous leads OR new LBBB\n- NSTEMI: Troponin elevation WITHOUT ST elevation\n\nBIOMARKERS:\n- Troponin I/T: Rise detectable 2-4h, peak 12-48h, elevated 4-14 days\n- High-sensitivity troponin: Earlier detection (0h, 1h, 3h protocols)\n\nTREATMENT:\n- STEMI: Immediate reperfusion (PCI <90min or thrombolysis <30min)\n- NSTEMI: Risk stratification (TIMI/GRACE score), early invasive vs conservative\n- Antiplatelet: Dual antiplatelet therapy (aspirin + P2Y12 inhibitor)\n- Anticoagulation: Heparin/enoxaparin\n- Adjuncts: Beta-blocker, ACE-I, statin",
  "metadata": {
    "category": "cardiovascular",
    "diagnosis": "myocardial_infarction",
    "priority": "CRITICAL",
    "source": "Fourth Universal Definition of MI (2018)"
  }
}
